Opana
-
Judge Approves Malvern-Based Endo’s $93,000 Incentives, Employee Bonuses Stalled
Malvern opioid maker Endo International has the greenlight to pay $93,000 in incentives to employees and sales reps, writes Bob Fernandez for The Philadelphia Inquirer.…
-
Wall Street Journal: Swamped by Thousands of Opioid-Related Lawsuits, Malvern’s Endo Hires Restructurer
Endo International — based in Dublin, Ireland, with a U.S. headquarters in Malvern — has hired a financial restructuring firm to navigate its current legal…
-
FTC Complaint: Endo Paid Companies to Delay Generic Pills
The Federal Trade Commission has filed a complaint against Malvern’s Endo Pharmaceuticals and several other drug companies in federal district court, alleging they violated antitrust laws, writes…
-
Endo Agrees to Pay Up After Prescription Drug Abuse
The Malvern pharmaceutical giant with the nation’s prescription narcotic of choice will pay a $200,000 penalty and cut ties with doctors who may be helping…
















































